Which has preferable valuation and earnings, DXCM or ALGN?

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 7.22 $836.30M $2.53 35.24 Align Technology $4.14B 2.97 $410.35M $5.75 29.84

Is DXCM or ALGN more profitable?

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 20.12% 35.94% 14.75% Align Technology 9.99% 15.86% 10.32%

Does the media favor DXCM or ALGN?

In the previous week, DexCom had 2 more articles in the media than Align Technology. MarketBeat recorded 14 mentions for DexCom and 12 mentions for Align Technology. Align Technology's average media sentiment score of 1.10 beat DexCom's score of 1.02 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 7 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HQY or ALGN?

In the previous week, HealthEquity and HealthEquity both had 12 articles in the media. Align Technology's average media sentiment score of 1.10 beat HealthEquity's score of 0.97 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HSIC or ALGN?

In the previous week, Henry Schein and Henry Schein both had 12 articles in the media. Align Technology's average media sentiment score of 1.10 beat Henry Schein's score of 0.57 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Is MEDP or ALGN more profitable?

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.67% 110.15% 24.84% Align Technology 9.99% 15.86% 10.32%

Does the media refer more to MEDP or ALGN?

In the previous week, Align Technology had 4 more articles in the media than Medpace. MarketBeat recorded 12 mentions for Align Technology and 8 mentions for Medpace. Align Technology's average media sentiment score of 1.10 beat Medpace's score of 0.98 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, ALGN or QTRX?

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Align Technology $4.14B 2.97 $410.35M $5.75 29.84 Quanterix $138.90M 0.87 -$107.15M -$2.63 N/A

Does the media prefer ALGN or QTRX?

In the previous week, Align Technology had 3 more articles in the media than Quanterix. MarketBeat recorded 12 mentions for Align Technology and 9 mentions for Quanterix. Align Technology's average media sentiment score of 1.10 beat Quanterix's score of -0.44 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Quanterix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral

Align Technology (ALGN) Competitors

$171.58 -1.38 (-0.80%)

As of 11:10 AM Eastern

Compare

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? Align Technology's main competitors and comparable companies include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Align Technology compare to DexCom?

DexCom (NASDAQ:DXCM) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	7.22	$836.30M	$2.53	35.24
Align Technology	$4.14B	2.97	$410.35M	$5.75	29.84

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	20.12%	35.94%	14.75%
Align Technology	9.99%	15.86%	10.32%

DexCom has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market.

DexCom presently has a consensus target price of $88.71, indicating a potential downside of 0.50%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 20.27%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, DexCom had 2 more articles in the media than Align Technology. MarketBeat recorded 14 mentions for DexCom and 12 mentions for Align Technology. Align Technology's average media sentiment score of 1.10 beat DexCom's score of 1.02 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	7 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

97.8% of DexCom shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

DexCom beats Align Technology on 12 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market.

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.34B	6.53	$215.20M	$2.67	39.14
Align Technology	$4.14B	2.97	$410.35M	$5.75	29.84

In the previous week, HealthEquity and HealthEquity both had 12 articles in the media. Align Technology's average media sentiment score of 1.10 beat HealthEquity's score of 0.97 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.25% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Align Technology	9.99%	15.86%	10.32%

HealthEquity presently has a consensus price target of $110.93, suggesting a potential upside of 6.15%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 20.27%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.6% of HealthEquity shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Align Technology beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.75	$398M	$3.43	26.01
Align Technology	$4.14B	2.97	$410.35M	$5.75	29.84

In the previous week, Henry Schein and Henry Schein both had 12 articles in the media. Align Technology's average media sentiment score of 1.10 beat Henry Schein's score of 0.57 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market.

Align Technology has a net margin of 9.99% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Align Technology	9.99%	15.86%	10.32%

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Henry Schein currently has a consensus price target of $92.27, suggesting a potential upside of 3.43%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 20.27%. Given Align Technology's stronger consensus rating and higher possible upside, analysts clearly believe Align Technology is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

Align Technology beats Henry Schein on 11 of the 15 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Medpace (NASDAQ:MEDP) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Medpace currently has a consensus price target of $584.18, suggesting a potential downside of 2.01%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 20.27%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	11 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.15
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Align Technology had 4 more articles in the media than Medpace. MarketBeat recorded 12 mentions for Align Technology and 8 mentions for Medpace. Align Technology's average media sentiment score of 1.10 beat Medpace's score of 0.98 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market.

Medpace has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.58	$451.12M	$17.06	34.94
Align Technology	$4.14B	2.97	$410.35M	$5.75	29.84

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Align Technology	9.99%	15.86%	10.32%

78.0% of Medpace shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 20.5% of Medpace shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Align Technology beats Medpace on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Align Technology (NASDAQ:ALGN) and Quanterix (NASDAQ:QTRX) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

88.4% of Align Technology shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 0.8% of Align Technology shares are held by insiders. Comparatively, 1.5% of Quanterix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Align Technology presently has a consensus price target of $206.36, suggesting a potential upside of 20.27%. Quanterix has a consensus price target of $3.50, suggesting a potential upside of 36.93%. Given Quanterix's higher probable upside, analysts plainly believe Quanterix is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Align Technology has a net margin of 9.99% compared to Quanterix's net margin of -80.25%. Align Technology's return on equity of 15.86% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Quanterix	-80.25%	-24.77%	-17.98%

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.97	$410.35M	$5.75	29.84
Quanterix	$138.90M	0.87	-$107.15M	-$2.63	N/A

In the previous week, Align Technology had 3 more articles in the media than Quanterix. MarketBeat recorded 12 mentions for Align Technology and 9 mentions for Quanterix. Align Technology's average media sentiment score of 1.10 beat Quanterix's score of -0.44 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Quanterix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

Summary

Align Technology beats Quanterix on 15 of the 17 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALGN vs. The Competition

Export

Metric	Align Technology	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.28B	$5.78B	$7.02B	$12.93B
Dividend Yield	N/A	1.77%	2.58%	10.34%
P/E Ratio	29.83	24.80	268.79	25.20
Price / Sales	2.97	61.81	574.32	73.36
Price / Cash	14.83	33.38	72.26	50.42
Price / Book	2.90	5.87	13.13	6.21
Net Income	$410.35M	$148.05M	$3.44B	$347.28M
7 Day Performance	-1.86%	1.71%	2.07%	1.33%
1 Month Performance	-4.39%	1.49%	-0.31%	-0.61%
1 Year Performance	22.13%	8.32%	70.62%	20.90%

Align Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALGN Align Technology	4.3482 of 5 stars	$171.58 -0.8%	$206.36 +20.3%	+28.3%	$12.28B	$4.14B	29.83	20,290	Positive News
DXCM DexCom	4.3032 of 5 stars	$87.31 +4.6%	$88.46 +1.3%	+15.0%	$31.49B	$4.66B	34.51	11,000	Gap Up
HQY HealthEquity	3.9759 of 5 stars	$104.36 +3.7%	$110.93 +6.3%	+14.2%	$8.41B	$1.31B	39.09	2,814
HSIC Henry Schein	2.4196 of 5 stars	$86.51 +0.9%	$89.36 +3.3%	+34.9%	$9.77B	$13.18B	26.14	25,000	Analyst Downgrade
MEDP Medpace	3.5232 of 5 stars	$573.29 -0.7%	$584.18 +1.9%	+34.6%	$16.11B	$2.53B	33.60	6,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 8/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Summary

How does Align Technology compare to HealthEquity?

Summary

How does Align Technology compare to Henry Schein?

Summary

How does Align Technology compare to Medpace?

Summary

How does Align Technology compare to Quanterix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Which has preferable valuation and earnings, DXCM or ALGN?

Is DXCM or ALGN more profitable?

Which has more risk and volatility, DXCM or ALGN?

Do analysts rate DXCM or ALGN?

Does the media favor DXCM or ALGN?

Do insiders and institutionals believe in DXCM or ALGN?

Summary

How does Align Technology compare to HealthEquity?

Which has more risk & volatility, HQY or ALGN?

Which has better earnings and valuation, HQY or ALGN?

Does the media favor HQY or ALGN?

Is HQY or ALGN more profitable?

Do analysts prefer HQY or ALGN?

Do insiders and institutionals have more ownership in HQY or ALGN?

Summary

How does Align Technology compare to Henry Schein?

Which has preferable valuation and earnings, HSIC or ALGN?

Does the media prefer HSIC or ALGN?

Which has more risk & volatility, HSIC or ALGN?

Is HSIC or ALGN more profitable?

Do insiders and institutionals hold more shares of HSIC or ALGN?

Do analysts rate HSIC or ALGN?

Summary

How does Align Technology compare to Medpace?

Do analysts recommend MEDP or ALGN?

Does the media refer more to MEDP or ALGN?

Which has more risk & volatility, MEDP or ALGN?

Which has better valuation and earnings, MEDP or ALGN?

Is MEDP or ALGN more profitable?

Do institutionals & insiders hold more shares of MEDP or ALGN?

Summary

How does Align Technology compare to Quanterix?

Do institutionals & insiders hold more shares of ALGN or QTRX?

Do analysts rate ALGN or QTRX?

Is ALGN or QTRX more profitable?

Which has stronger valuation & earnings, ALGN or QTRX?

Does the media prefer ALGN or QTRX?

Which has more volatility & risk, ALGN or QTRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools